[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bayer A G Ord (BAYZF)

Bayer A G Ord (BAYZF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 20.57
  • Price/Book 5.23
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.7300 +0.95%
on 04/29/26
48.9100 -13.87%
on 04/17/26
-1.5050 (-3.45%)
since 03/27/26
3-Month
41.3100 +1.97%
on 03/04/26
58.3276 -27.78%
on 02/17/26
-10.9450 (-20.62%)
since 01/29/26
52-Week
24.9000 +69.18%
on 05/14/25
58.3276 -27.78%
on 02/17/26
+15.7300 (+59.59%)
since 04/29/25

Most Recent Stories

More News
Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

KEY FACTS Two late-breaking presentations from the landmark OCEANIC-STROKE study will provide new insights into ischemic strokes that occurred during the trial, as well...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing

The Latest Breakthrough Study from Leaps by Bayer and BCG reveals why optimism varies by technology, region, and context, with varying trends in China, Germany, and the US Younger generations...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class

Bayer Canada is proud to support the Simon Fraser University (SFU) School of Medicine - the first medical school in Western Canada in nearly 60 years. The new school is dedicated to help improve primary...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

Nelson Ambrogio appointed to lead U.S. pharmaceuticals business, Bayer’s largest pharmaceutical growth market Appointment supports Bayer Pharmaceuticals’ strategy to renew top-line...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative

Bayer challenges industry to redefine canola innovation and reframe canola's future around real, lasting systems.

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
Multiplatinum Rapper, Actor Ludacris Partners with One A Day® to Help People Realize that Health Does Not Need to Be Ludacris

The social-first campaign humorously tackles extreme wellness trends while showcasing how Ludacris incorporates One A Day ® multivitamins...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
Bayer Crop Science Launches 2026 Opportunity Scholarship Program

Bayer Crop Science Canada is excited to support the future of Canadian agriculture with its 2026 Bayer Crop Science Opportunity Scholarship. Through the scholarship, students entering post-secondary...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease

KERENDIA ® (finerenone) met its primary endpoint demonstrating a statistically significant improvement vs. placebo in the estimated glomerular filtration rate (eGFR) slope from baseline...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments

Clearance reinforces Bayer’s continued commitment to dependable, integrated radiology solutions Expanded Tesla compatibility captures...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)
Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

  225 Ac-PSMA-Trillium (BAY 3563254) is an investigational targeted alpha therapy (TAT) being developed for patients with advanced metastatic castration-resistant prostate cancer (mCRPC)...

BAYRY : 11.0600 (+4.93%)
BAYZF : 42.1250 (-2.71%)
BAYN : 0.0100 (unch)

Business Summary

Bayer AG is an international research-based company active in life sciences, polymers, and chemicals. Bayer's operating units include health-care products, material sciences, and crop sciences. Bayer's over-the-counter health-care product division is the third-largest in the world. HealthCare subgroup...

See More

Key Turning Points

3rd Resistance Point 42.6900
2nd Resistance Point 42.4190
1st Resistance Point 42.2720
Last Price 42.1250
1st Support Level 41.8540
2nd Support Level 41.5830
3rd Support Level 41.4360

See More

52-Week High 58.3276
Fibonacci 61.8% 45.5583
Last Price 42.1250
Fibonacci 50% 41.6138
Fibonacci 38.2% 37.6693
52-Week Low 24.9000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.